Publication

Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion

Adrian Schmid
2022
Journal Articles

Abstract

Background: Alzheimer's disease (AD) remains to date an incurable disease with a long asymptomatic phase. Early diagnosis in peripheral biofluids has emerged as key for identifying subjects at risk and developing therapeutics and preventative approaches.

Official source

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion

Chat with Graph Search

Discovery of macrocyclic inhibitors of challenging protein-protein interactions

Effective Inhibition of TDP-43 Aggregation by Native State Stabilization

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates